해부 병리 이력관리 솔루션 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

Anatomic Pathology Track & Trace Solution Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End User, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,497,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,940,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,550,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 해부 병리 이력관리 솔루션 시장 규모는 2024년 6억 7,392만 달러로, 예측 기간 중 7.48%의 연평균 복합 성장률(CAGR)로 2030년에는 10억 4,136만 달러에 달할 것으로 예상됩니다.

세계 해부병리 이력관리 솔루션 시장은 헬스케어 및 의료 기술 산업의 한 분야입니다. 조직 샘플이나 생검 재료와 같은 해부병리 표본의 수집부터 처리, 분석, 보고에 이르는 과정을 추적하고 추적하기 위해 첨단 기술을 사용합니다. 이러한 솔루션은 환자의 안전을 개선하고, 오류를 줄이며, 병리 실험실의 효율성을 높이는 데 중요한 역할을 합니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	6억 7,392만 달러
시장 규모 : 2030년	10억 4,136만 달러
CAGR: 2025-2030년	7.48%
급성장 부문	슬라이드 추적
최대 시장	북미

시장 성장 촉진요인

정밀진단에 대한 수요 증가

주요 시장 이슈

데이터 프라이버시 및 보안

주요 시장 동향

블록체인을 통한 보안 강화

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 해부 병리 이력관리 솔루션 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 용도별(슬라이드 추적, 표본 추적, 조직 카세트 및 블록 추적)
  • 최종 용도별(병원 검사실, 독립·참조 검사실, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 해부 병리 이력관리 솔루션 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 캐나다
  • 멕시코

제7장 유럽의 해부 병리 이력관리 솔루션 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 해부 병리 이력관리 솔루션 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 해부 병리 이력관리 솔루션 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 해부 병리 이력관리 솔루션 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병과 인수(해당하는 경우)
• 제품의 발매(해당하는 경우)
• 최근 동향

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Leica Biosystems Nussloch GmbH
• Thermo Fisher Scientific Inc
• Zebra Technologies Corp.
• Agilent Technologies Inc
• CompuGroup Medical
• LigoLab Information Systems
• General Data Healthcare Inc.
• Psyche Systems Corporation
• Siemens Healthineers AG
• Indica Labs, LLC

제15장 전략적 제안

제16장 조사회사 소개·면책사항

KSA

영문 목차

영문목차

Global Anatomic Pathology Track & Trace Solution Market was valued at USD 673.92 Million in 2024 and is expected to reach USD 1041.36 Million by 2030 with a CAGR of 7.48% during the forecast period. The Global Anatomic Pathology Track & Trace Solution Market is a segment within the broader healthcare and medical technology industry. It involves the use of advanced technologies to track and trace the journey of anatomical pathology specimens, such as tissue samples and biopsy materials, from collection through processing, analysis, and reporting. These solutions play a crucial role in improving patient safety, reducing errors, and enhancing the efficiency of pathology laboratories.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 673.92 Million
Market Size 2030	USD 1041.36 Million
CAGR 2025-2030	7.48%
Fastest Growing Segment	Slides Tracking
Largest Market	North America

Key Market Drivers

Rising Demand for Precise Diagnostics

In the ever-advancing realm of healthcare, precision and accuracy in diagnostics are pivotal. Accurate and timely diagnosis not only ensures better patient outcomes but also drives the development of effective treatment plans. The Global Anatomic Pathology Track & Trace Solution Market has emerged as an indispensable player in enhancing the precision of diagnostic processes, and its growth is significantly bolstered by the escalating demand for precise diagnostics.

Key Market Challenges

Data Privacy and Security

In today's digital age, data privacy and security have become paramount concerns, particularly in healthcare environments. The collection, storage, and transfer of sensitive patient information through track and trace solutions present significant risks if not managed correctly. These solutions gather various forms of data, including personal health records, diagnostic results, and treatment histories, all of which must be protected to ensure patient confidentiality. Healthcare institutions are held to stringent regulations, such as HIPAA (Health Insurance Portability and Accountability Act) in the U.S. or GDPR (General Data Protection Regulation) in Europe, that mandate the safeguarding of patient data.

Key Market Trends

Blockchain for Enhanced Security

In the healthcare sector, where data security and privacy are of utmost importance, blockchain technology presents a promising solution to safeguard sensitive patient and diagnostic information. Blockchain's decentralized ledger system provides a high level of security by ensuring that once data is recorded, it cannot be altered or tampered with. This makes blockchain an ideal candidate for enhancing track and trace systems, especially for handling medical records, test results, and specimen data. By leveraging blockchain, healthcare institutions can ensure that all diagnostic data remains authentic and immutable, effectively preventing fraud and reducing the risk of data breaches.

Key Market Players

• Leica Biosystems Nussloch GmbH
• Thermo Fisher Scientific Inc
• Zebra Technologies Corp.
• Agilent Technologies Inc
• CompuGroup Medical
• LigoLab Information Systems
• General Data Healthcare Inc.
• Psyche Systems Corporation
• Siemens Healthineers AG
• Indica Labs, LLC

Report Scope:

In this report, the Global Anatomic Pathology Track & Trace Solution Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anatomic Pathology Track & Trace Solution Market, By Application:

• Slides Tracking
• Specimen Tracking
• Tissue Cassettes & Blocks Tracking

Anatomic Pathology Track & Trace Solution Market, By End User:

• Hospital Laboratories
• Independent & Reference Laboratories
• Others

Anatomic Pathology Track & Trace Solution Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anatomic Pathology Track & Trace Solution Market.

Available Customizations:

Global Anatomic Pathology Track & Trace Solution market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anatomic Pathology Track & Trace Solution Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Slides Tracking, Specimen Tracking, Tissue Cassettes & Blocks Tracking)
  • 5.2.2. By End User (Hospital Laboratories, Independent & Reference Laboratories, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Anatomic Pathology Track & Trace Solution Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anatomic Pathology Track & Trace Solution Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Anatomic Pathology Track & Trace Solution Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Anatomic Pathology Track & Trace Solution Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By End User

7. Europe Anatomic Pathology Track & Trace Solution Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By End User
  • 7.3.4. France Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Anatomic Pathology Track & Trace Solution Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By End User

8. Asia-Pacific Anatomic Pathology Track & Trace Solution Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By End User
  • 8.3.2. India Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Anatomic Pathology Track & Trace Solution Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By End User

9. South America Anatomic Pathology Track & Trace Solution Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Anatomic Pathology Track & Trace Solution Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Anatomic Pathology Track & Trace Solution Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Anatomic Pathology Track & Trace Solution Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By End User

10. Middle East and Africa Anatomic Pathology Track & Trace Solution Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Anatomic Pathology Track & Trace Solution Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Anatomic Pathology Track & Trace Solution Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Anatomic Pathology Track & Trace Solution Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Leica Biosystems Nussloch GmbH
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Thermo Fisher Scientific Inc
• 14.3. Zebra Technologies Corp.
• 14.4. Agilent Technologies Inc
• 14.5. CompuGroup Medical
• 14.6. LigoLab Information Systems
• 14.7. General Data Healthcare Inc.
• 14.8. Psyche Systems Corporation
• 14.9. Siemens Healthineers AG
• 14.10. Indica Labs, LLC

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료